CAM
LLY icon

Cresset Asset Management’s Eli Lilly LLY Stock Holding History

Cresset Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.8M Sell
51,989
-8,648
-14% -$8.77M 0.21% 78
2025
Q4 		$65.2M Buy
60,637
+411
+0.7% +$393K 0.27% 63
2025
Q3 		$46M Sell
60,226
-1,259
-2% -$937K 0.2% 75
2025
Q2 		$47.9M Sell
61,485
-6,198
-9% -$4.82M 0.24% 69
2025
Q1 		$55.9M Sell
67,683
-11,307
-14% -$9.41M 0.28% 57
2024
Q4 		$61M Sell
78,990
-54,144
-41% -$44.8M 0.29% 52
2024
Q3 		$118M Buy
133,134
+2,231
+2% +$2.01M 0.45% 33
2024
Q2 		$119M Buy
130,903
+30,044
+30% +$24M 0.5% 29
2024
Q1 		$78.5M Buy
100,859
+8,492
+9% +$6.04M 0.38% 39
2023
Q4 		$53.8M Buy
92,367
+6,101
+7% +$3.56M 0.32% 44
2023
Q3 		$46.3M Sell
86,266
-270
-0.3% -$139K 0.18% 62
2023
Q2 		$40.6M Buy
86,536
+51,504
+147% +$21.6M 0.05% 117
2023
Q1 		$12M Sell
35,032
-95,564
-73% -$32.2M 0.24% 72
2022
Q4 		$46.9M Sell
130,596
-10
-0% -$3.55K 0.59% 30
2022
Q3 		$42.2M Buy
130,606
+6,040
+5% +$1.91M 0.53% 26
2022
Q2 		$39.9M Sell
124,566
-2,517
-2% -$756K 0.49% 26
2022
Q1 		$36.4M Sell
127,083
-6,224
-5% -$1.6M 0.38% 33
2021
Q4 		$36.8M Buy
133,307
+7,332
+6% +$1.86M 0.36% 34
2021
Q3 		$29.1M Sell
125,975
-7,592
-6% -$1.87M 0.39% 27
2021
Q2 		$30.7M Buy
133,567
+7,315
+6% +$1.47M 0.43% 25
2021
Q1 		$23.6M Buy
126,252
+3,799
+3% +$743K 0.37% 29
2020
Q4 		$20.7M Sell
122,453
-4,559
-4% -$681K 0.34% 29
2020
Q3 		$18.8M Buy
127,012
+235
+0.2% +$36.4K 0.35% 28
2020
Q2 		$20.8M Buy
126,777
+11,946
+10% +$1.83M 0.46% 26
2020
Q1 		$15.9M Buy
114,831
+4,922
+4% +$676K 0.48% 26
2019
Q4 		$14.4M Buy
109,909
+1,128
+1% +$131K 0.39% 27
2019
Q3 		$12.2M Buy
108,781
+1,053
+1% +$117K 0.37% 31
2019
Q2 		$11.9M Sell
107,728
-9,814
-8% -$1.16M 0.37% 41
2019
Q1 		$15.3M Buy
117,542
+31,204
+36% +$3.79M 0.59% 18
2018
Q4 		$9.99M Buy
+86,338
New +$9.64M 0.59% 18

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cresset Asset Management's LLY Position: Q1 2026 in Review

Cresset Asset Management reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $8.77M and leaving 51,989 shares worth $47.8M. The position accounts for 0.21% of the portfolio, ranked #78.

Cresset Asset Management first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $119M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cresset Asset Management held 51,989 shares of Eli Lilly worth $47.8M as of Q1 2026.
  • Cresset Asset Management sold 8,648 Eli Lilly shares in Q1 2026, an estimated $8.77M.
  • Eli Lilly made up 0.21% of Cresset Asset Management's portfolio in Q1 2026, its #78 holding.
  • Cresset Asset Management first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's Eli Lilly position peaked at $119M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.